Lymphoplasmacytic Lymphoma Active Not Recruiting Phase 1 / 2 Trials for Clofarabine (DB00631)

IndicationStatusPhase
DBCOND0031072 (Lymphoplasmacytic Lymphoma)Active Not Recruiting1 / 2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00644189Oral Clofarabine for Relapsed/Refractory Non-Hodgkin LymphomaTreatment